�Samprada & Nanhamati Singh Family Trust has submitted to exchange a copy of Disclosure with respect to Samprada and Nanhamati Singh Family Trust.
ALKEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Samprada & Nanhamati Singh Family Trust, part of the promoter group of Alkem Laboratories, sold 0.67% of the company's shares on June 11, 2025. Following this sale, the Trust's holding in Alkem has reduced from 19.41% to 18.74%. The proceeds from the sale were distributed to the beneficiaries of the Trust. The disclosure is being made under a SEBI exemption order dated March 10, 2017, which requires the Trust to report any changes in its shareholding. The Trust continues to remain a significant shareholder in the company post the transaction.
This is a small reduction (less than 1%) in promoter group holding and is unlikely to materially affect the stock price. However, it indicates some monetisation by promoter-related entities, which retail investors may monitor for further reductions.